Showing results (841-850 of 2,811) with videos related to
Sort By:
Pageof 282
Expert Opinion on Drug Safety|September 1, 2004
Drug-induced urticariaEunice K H Tan, Clive E H GrattanExpert Opinion on Drug Safety|January 21, 2022
Barriers and facilitators for systematically registering adverse drug reactions in electronic health records: a qualitative study with Dutch healthcare professionalsIsa P A C Geeven, Naomi T Jessurun, Arthur T M Wasylewicz, et al.Expert Opinion on Drug Safety|May 5, 2016
Safety of available treatment options for renal cell carcinomaLisa Derosa, Laurence Albiges, Christophe Massard, et al.Expert Opinion on Drug Safety|February 9, 2021
Risks and benefits of reducing the number of drugs to treat HIV-1 infectionJulen Cadiñanos, Rocio Montejano, Rosa de Miguel Buckley, et al.Expert Opinion on Drug Safety|February 19, 2021
Is there any clinical or laboratory predictive factor for cetuximab-induced skin toxicity?Yusuf Acikgoz, Oznur Bal, Gokhan Ucar, et al.Expert Opinion on Drug Safety|August 3, 2019
Fixed-dose combinations banned in India: is it the right decision? An eye-opening reviewMarlon Ramcy Henry Miranda, Akhilesh Dubey, Ravi G S, et al.Expert Opinion on Drug Safety|September 21, 2019
Making medicines safer: analysis of patient reports to the UK's Yellow Card SchemeB O' Donovan, Ruth M Rodgers, Anthony R Cox, et al.Expert Opinion on Drug Safety|August 21, 2019
Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence - an updateCéline J Fischer Fumeaux, Mathilde Morisod Harari, Etienne Weisskopf, et al.Expert Opinion on Drug Safety|September 19, 2019
The efficacy and safety of amifostine for the acute radiation syndromeVijay K Singh, Thomas M SeedExpert Opinion on Drug Safety|September 4, 2019
The safety of anti-interleukins monoclonal antibodies for the treatment of psoriasisS D'Adamio, D Silvaggio, P Lombardo, et al.Pageof 282